Inhibition of Growth and Induction of Differentiation of Glioma Cell Lines by Oncostatin M (OSM)

References

• Amaral M. C., Miles S., Kumar G., Nel A. E. Oncostatin-M stimulates tyrosine protein phosphorylation in parallel with the activation of p42MAPK/ERK-2 in Kaposi's cells. Evidence that this pathway is important in Kaposi cell growth. J. Clin. Invest. 1993; 92: 848–857
   PubMed Web of Science ®Google Scholar
• Bazan J. F. Neuropoietic cytokines in the hematopoietic fold. Neuron 1991; 7: 197–208
   PubMed Web of Science ®Google Scholar
• Bottenstein J., Hayashi I., Hutchings S., Masui H., Mather J., McClure D. B., Rizzino A., Sato G., Serrero G., Wolfe R., Wu R. The growth of cells in serum-free hormone-supplemented media. Methods Enzymol. 1979; 58: 94–109
   PubMedGoogle Scholar
• Bruce A. G., Linsley P. S., Rose T. M. Oncostatin M. Prog. Growth Factor. Res. 1992; 4: 157–170
   PubMedGoogle Scholar
• Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidiniumthiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987; 162: 156–159
   PubMed Web of Science ®Google Scholar
• Davis S., Aldrich T. H., Valenzuela D. M., Wong V. V., Furth M. E., Squinto S. P., Yancopoulos G. D. The receptor for ciliary neurotrophic factor. Science 1991; 253: 59–63
   PubMed Web of Science ®Google Scholar
• Ekstrand A. J., James C. D., Cavenee W. K., Seliger B., Pettersson R. F., Collins V. P. Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res. 1991; 51: 2164–2172
   PubMed Web of Science ®Google Scholar
• Gearing D. P., Comeau M. R., Friend D. J., Gimpel S. D., Thut C. J., McGourty J., Brasher K. K., King J. A., Gillis S., Mosley B., Ziegler S. F., Cosman D. The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Science 1992; 255: 1434–1437
   PubMed Web of Science ®Google Scholar
• Grove R. I., Eberhardt C., Abid S., Mazzucco C., Liu J., Kiener P., Todaro G., Shoyab M. Oncostatin M is a mitogen for rabbit vascular smooth muscle cells. Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 823–827
   PubMed Web of Science ®Google Scholar
• Hilton D. J., Hilton A. A., Raicevic A., Rakar S., Harrison Smith M., Gough N. M., Metcalf D., Nicola N. A., Willson T. A. Cloning of a murine IL-11 receptor alpha-chain; requirement for gp130 for high affinity binding and signal transduction. EMBO J. 1994; 13: 4765–4775
   PubMed Web of Science ®Google Scholar
• Horn D., Fitzpatrick W. C., Gompper P. T., Ochs V., Bolton Hansen M., Zarling J., Todaro G. J., Linsley P. S. Regulation of cell growth by recombinant oncostatin M. Growth Factors. 1990; 2: 157–165
   PubMedGoogle Scholar
• Libermann T. A., Nusbaum H. R., Razon N., Kris R., Lax I., Soreq H., Whittle N., Waterfield M. D., Ullrich A., Schlessinger J. Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature 1985; 313: 144–147
   PubMed Web of Science ®Google Scholar
• Liu J., Modrell B., Aruffo A., Marken J. S., Taga T., Yasukawa K., Murakami M., Shoyab M. Interleukin-6 signal transducer gp130 mediates oncostatin M signaling. J. Biol. Chem. 1992; 267: 16763–16766
   PubMed Web of Science ®Google Scholar
• Maniatis T., Fritsch E. F., Sambrook J. Molecular cloning: A laboratory manual.2nd edition. Cold Spring Habor Laboratory, Cold Spring Habor, N.Y. 1989; 7.39–7.53
   Google Scholar
• Marushige Y., Raju N. R., Marushige K., Koestner A. Modulation of growth and of morphological characteristics in glioma cells by nerve growth factor and glia maturation factor. Cancer Res. 1987; 47: 4109–4115
   PubMedGoogle Scholar
• Marushige Y., Marushige K., Koestner A. Growth inhibition of anaplastic glioma cells by nerve growth factor. Anticancer Res. 1992; 12: 2069–2073
   PubMedGoogle Scholar
• Malik N., Kallestad J. C., Gunderson N. L., Austin S. D., Neubauer M. G., Ochs V., Marquardt H., Zarling J. M., Shoyab M., Wei C. M., Linsley P. S., Rose T. M. Molecular cloning, sequence analysis, and functional expression of a novel growth regulator, oncostatin M. Mol. Cell. Biol. 1989; 9: 2847–2853
   PubMed Web of Science ®Google Scholar
• Miles S. A., Martinez Maza O., Rezai A., Magpantay L., Kishimoto T., Nakamura S., Linsley P. S. Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells. Science 1992; 255: 1432–1434
   PubMed Web of Science ®Google Scholar
• Mosley B., De Imus C., Friend D., Boiani N., Thoma B., Park L. S., Cosman D. Dual oncostatin M (OSM) receptors—Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J. Biol. Chem. 1996; 271: 32635–32643
   PubMed Web of Science ®Google Scholar
• Nair B. C., De Vico A. L., Nakamura S., Copeland T. D., Chen Y., Patel A., O'Neil T., Gallo R. C., Sarngadharan M. G. Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M. Science 1992; 255: 1430–1432
   PubMed Web of Science ®Google Scholar
• Pennica D., Shaw K. J., Swanson T. A., Moore M. W., Shelton D. L., Zioncheck K. A., Rosenthal A., Taga T., Paoni N. F., Wood W. I. Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp 130 signaling complex. J. Biol. Chem. 1995; 270: 10915–10922
   PubMed Web of Science ®Google Scholar
• Ram Z., Samid D., Walbridge S., Oshiro E. M., Viola J. J., Tao Cheng J. H., Shack S., Myers C. E., Oldfield E. H. Growth inhibition, tumor maturation, and extended survival in experimental brain tumors in rats treated with phenylacetate. Cancer Res. 1994; 54: 2923–2927
   PubMedGoogle Scholar
• Rutka J. T., Giblin J. R., Apodaca G., De Armond S. J., Stern R., Rosenblum M. L. Inhibition of growth and induction of differentiation in a malignant human glioma cell line by normal leptomeningeal extracellular matrix proteins. Cancer Res. 1987; 47: 3515–3522
   PubMedGoogle Scholar
• Schultz J., Dettlaff S., Fritzsche U., Harms U., Schiebel H., Derer W., Hulsen A., Bohm M. The amido black assay: a simple and quantitative multipurpose test of adhesion, proliferation, and cytotoxicity in microplate cultures of keratinocytes (HaCaT) and other cell types growing adherently or in suspension. J. Immunol. Methods 1994; 167: 1–13
   PubMedGoogle Scholar
• Stahl N., Boulton T. G., Farruggella T., Ip N. Y., Davis S., Witthuhn B. A., Quelle F. W., Silvennoinen O., Barbieri G., Pellegrini S., Ihle J. N., Yancopoulos G. D. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 β receptor components. Science 1994; 263: 92–95
   PubMed Web of Science ®Google Scholar
• Stockhammer G., Manley G. T., Johnson R., Rosenblum M. K., Samid D., Lieberman F. S. Inhibition of proliferation and induction of differentiation in medulloblastoma-and astrocytoma-derived cell lines with phenylacetate. J. Neurosurg. 1995; 83: 672–681
   PubMed Web of Science ®Google Scholar
• Tanaka S., Nagashima T., Manaka S., Hori T., Yasumoto S. Growth suppression and astrocytic differentiation of glioma cells by interleukin-1. J. Neurosurg. 1994; 81: 402–410
   PubMedGoogle Scholar
• Thoma B., Bird T. A., Friend D. J., Gearing D. P., Dower S. K. Oncostatin M and leukemia inhibitory factor trigger overlapping and different signals through partially shared receptor complexes. J. Biol. Chem. 1994; 269: 6215–6222
   PubMed Web of Science ®Google Scholar
• Wong A. J., Bigner S. H., Bigner D. D., Kinzler K. W., Hamilton S. R., Vogelstein B. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc. Natl. Acad. Sci. U. S. A. 1987; 84: 6899–6903
   PubMed Web of Science ®Google Scholar
• Yamasaki K., Taga T., Hirata Y., Yawata H., Kawanishi Y., Seed B., Taniguchi T., Kishimoto T. Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor. Science 1988; 241: 825–828
   PubMed Web of Science ®Google Scholar
• Yoshimura A., Ichihara M., Kinjyo I., Moriyama M., Cope-Land N. G., Gilbert D. J., Jenkins N. A., Hara T., Miyajima A. Mouse oncostatin M: An immediate early gene induced by multiple cytokines through the JAK-STAT5 pathway. EMBO J. 1996; 15: 1055–1063
   PubMed Web of Science ®Google Scholar
• Zhang X. -G., Gu J.-J., Lu Z. -Y., Yasukawa K., Yancopoulos G. D., Turner K., Shoyab M., Taga T., Kishimoto T., Bataille R., Klein B. Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer GP130. J. Exp. Med. 1994; 179: 1337–1342
   PubMed Web of Science ®Google Scholar
• Zarling J. M., Shoyab M., Marquardt H., Hanson M. B., Lioubin M. N., Todaro G. J. Oncostatin M: A growth regulator produced by differentiated histiocytic lymphoma cells. Proc. Natl. Acad. Sci. U. S. A. 1986; 83: 9739–9743
   PubMed Web of Science ®Google Scholar